TO: [name] DATE: , 2014 RE: Waiver of Good ReasonWaiver of Good Reason • December 10th, 2014 • Avanir Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 10th, 2014 Company IndustryAs you may know, [Orange], Inc., a Delaware corporation (the “Company”) is in the process of negotiating an Agreement and Plan of Merger by and among , a Japanese joint stock company, Bigarade Corporation, a Delaware corporation and a direct or indirect wholly-owned subsidiary of Parent, and the Company (the “Merger Agreement”).